Frontiers in Immunology | Cancer Immunity and Immunotherapy

Case Report

Published on 02 May 2024

Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer

in Cancer Immunity and Immunotherapy

Can Lou
Meng Liu
Ting Ma
Liu Yang
Dan Long
Jiaming Li
Hang Lei
Dong Xiang
Xuefeng Wang
Lei Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390082

7,683 views
4 citations

Review

Published on 02 May 2024

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application

in Cancer Immunity and Immunotherapy

Rui Zheng
Xiaobin Liu
Yufu Zhang
Yongxian Liu
Yaping Wang
Shutong Guo
Xiaoyan Jin
Jing Zhang
Yuehong Guan
Yusi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383978

9,963 views
20 citations

Case Report

Published on 02 May 2024

Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC

in Cancer Immunity and Immunotherapy

Zheming Bao
Xiuchun Yu
Kai Zheng
Kai Zhai
Haocheng Cui
Ming Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372279

3,270 views

Editorial

Published on 01 May 2024

Editorial: New insights into cancer immunology of refractory GU and liver tumors: therapy and mechanism

in Cancer Immunity and Immunotherapy

Miao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420381

1,421 views

Review

Published on 01 May 2024

Charting new paradigms for CAR-T cell therapy beyond current Achilles heels

in Cancer Immunity and Immunotherapy

Ying Li
Zhenhua Hu
Yuanyuan Li
Xiaoyan Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409021

9,254 views
6 citations

Original Research

Published on 01 May 2024

Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature

in Cancer Immunity and Immunotherapy

Xukui Li
Xue Li
Bin Yang
Songyang Sun
Shu Wang
Fuxun Yu
Tao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1369289

3,106 views

Original Research

Published on 30 Apr 2024

Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system

in Cancer Immunity and Immunotherapy

Xueyan Liang
Hewei Xiao
Huijuan Li
Xiaoyu Chen
Yan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1396752

8,635 views
8 citations

Original Research

Published on 30 Apr 2024

Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis

in Cancer Immunity and Immunotherapy

Danielle Brazel
Christopher Grant
Angelo Cabal
Wen-Pin Chen
Lauren Pinter-Brown

Frontiers in Immunology

doi 10.3389/fimmu.2024.1334899

4,392 views
4 citations

Review

Published on 30 Apr 2024

Circulating tumor DNA: from discovery to clinical application in breast cancer

in Cancer Immunity and Immunotherapy

Jiachi Xu
Hongyu Gao
Xinyu Guan
Jiahao Meng
Shirong Ding
Qian Long
Wenjun Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1355887

7,744 views
15 citations

Editorial

Published on 30 Apr 2024

Editorial: Comprehensive profiling cancer immunity with multimodal approaches for clinical management

in Cancer Immunity and Immunotherapy

Geng Chen
Yi Shi
Wenming Xiao
David P. Kreil

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421576

1,352 views

Case Report

Published on 30 Apr 2024

Case report: Preventive infusion of donor-derived CD7 chimeric antigen receptor T cells after allogeneic hematopoietic stem cell transplantation

in Cancer Immunity and Immunotherapy

Ying Jiang
Dan Feng
Jun Zhu
Daolin Wei
Chuxian Zhao
Huixia Liu
Shan Shao
Chun Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1381308

2,126 views
3 citations

Original Research

Published on 30 Apr 2024

PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Yulai Liang
Huazao Luo
Xue Li
Shuang Liu
Arslan Habib
Baoxiu Liu
Jiansheng Huang
Jingbo Wang
Han Yi
Bo Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367040

5,052 views
4 citations

Original Research

Published on 30 Apr 2024

Designer umbilical cord-stem cells induce alveolar wall regeneration in pulmonary disease models

in Cancer Immunity and Immunotherapy

Mayumi Iwatake
Tokiko Nagamura-Inoue
Ryoichiro Doi
Yukinori Tanoue
Mitsutoshi Ishii
Hiroshi Yukawa
Keitaro Matsumoto
Koichi Tomoshige
Takeshi Nagayasu
Tomoshi Tsuchiya

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384718

5,047 views
2 citations

Correction

Published on 29 Apr 2024

Corrigendum: Immunoglobulins and serum proteins impair anti-tumor NK cell effector functions in malignant ascites

in Cancer Immunity and Immunotherapy

Antonio Hrvat
Sonja Benders
Rainer Kimmig
Sven Brandau
Nina Mallmann-Gottschalk

Frontiers in Immunology

doi 10.3389/fimmu.2024.1420991

1,115 views

Methods

Published on 29 Apr 2024

Coupling imaging mass cytometry with Alcian blue histochemical staining for a single-slide approach

in Cancer Immunity and Immunotherapy

Patrice Hemon
Danivanh Ben-Guigui
Margaux Geier
Marine Castillon
Corentin Paranthoen
Jacques-Olivier Pers
Marion Le Rochais
Arnaud Uguen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379154

2,173 views

Original Research

Published on 29 Apr 2024

Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification

in Cancer Immunity and Immunotherapy

Guoqing Ouyang
Qiuyun Li
Yangnian Wei
Wenbin Dai
Haojian Deng
Youli Liu
Jiaguang Li
Mingjuan Li
Shunwen Luo
Shuang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1323199

6,517 views
13 citations